|Appears in Collections:||Aquaculture Journal Articles|
|Peer Review Status:||Refereed|
|Title:||Use of models for the environmental risk assessment of veterinary medicines in European aquaculture: current situation and future perspectives|
Van den Brink, Paul J
ter Horst, Mechteld
Telfer, Trevor C
environmental risk assessment
|Citation:||Rico A, Vighi M, Van den Brink PJ, ter Horst M, Macken A, Lillicrap A, Falconer L & Telfer TC (2019) Use of models for the environmental risk assessment of veterinary medicines in European aquaculture: current situation and future perspectives. Reviews in Aquaculture, 11 (4), pp. 969-988. https://doi.org/10.1111/raq.12274|
|Abstract:||Veterinary Medicinal Products (VMPs) are used in intensive aquaculture production to treat a wide range of bacterial and parasitic infestations. Their release into the environment poses concerns regarding their potential ecotoxicological risks to aquatic ecosystems, which need to be evaluated making use of appropriate Environmental Risk Assessment (ERA) schemes and models. This study presents an overview of the major aquaculture production systems in Europe, the VMPs most commonly used, and the environmental quality standards and regulatory procedures available for their ERA. Furthermore, it describes the state-of-the-art on the development of environmental models capable of assessing the fate, exposure, ecotoxicological effects and risks of VMPs in aquaculture production systems, and discusses their level of development and implementation within European aquaculture. This study shows that the use of environmental models in regulatory ERA is somewhat limited in many European countries. Major efforts have been dedicated to assess the fate and exposure of antiparasitic compounds in salmonid cage systems, particularly in Scotland, while models and scenarios for assessing dispersal of antimicrobials, in general, and antiparasitic compounds in the Mediterranean as well as in Scandinavian regions are less available. On the other hand, the use of ecological models for assessing the effects and risks of VMPs is almost absent. Recommendations are provided to improve the chemical exposure and effect assessments and the ecological realism of the modelling outcomes, paying special attention to the protection goals set for the regulatory ERA of VMPs in Europe|
|Rights:||This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study. This is the peer reviewed version of the following article: Rico, A., Vighi, M., Van den Brink, P.J., ter, Horst, M., Macken, A., Lillicrap, A., Falconer, L. and Telfer, T.C. (2019), Use of models for the environmental risk assessment of veterinary medicines in European aquaculture: current situation and future perspectives. Rev Aquacult, 11: 969-988, which has been published in final form at https://doi.org/10.1111/raq.12274. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for self-archiving.|
|Rico et al. 2018 RevAqua.pdf||Fulltext - Accepted Version||933.71 kB||Adobe PDF||View/Open|
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
If you believe that any material held in STORRE infringes copyright, please contact email@example.com providing details and we will remove the Work from public display in STORRE and investigate your claim.